# The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study

> **NCT00809029** · NA · UNKNOWN · sponsor: **Liverpool University Hospitals NHS Foundation Trust** · enrollment: 12 (estimated)

## Conditions studied

- Adipose Tissue

## Interventions

- **OTHER:** GIP (glucose dependent insulinotropic peptide) infusion

## Key facts

- **NCT ID:** NCT00809029
- **Lead sponsor:** Liverpool University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809029, "The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00809029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
